Researchers of Cusat granted patent for cancer immunotherapy

The patent was facilitated by the IPR facilitation cell at Inter University Centre for IPR Studies (IUCIPRS), Cusat.
Anjana Unnikrishnan, Anusha Ashokan, Meera Menon,
Anjana Unnikrishnan, Anusha Ashokan, Meera Menon,
Updated on
1 min read

KOCHI: A team of researchers from the Department of Biotechnology at Cochin University of Science and Technology (Cusat) has been granted a patent for a significant innovation in the field of cancer immunotherapy.

The team, comprising Dr Anusha Ashokan, former DST Inspire faculty, Meera Menon, senior research fellow, and Anjana Unnikrishnan, former project trainee, developed a novel adjuvant formulation based on aluminium-incorporated polymer nanoparticles.

The adjuvant, designed to enhance the efficacy of cancer vaccines, has been demonstrated to reduce tumour growth and improve anti-tumour immune response in mouse cancer model (melanoma). By improving the efficacy of cancer vaccines, it could offer a safer and more effective alternative to traditional cancer treatments.

The patent was facilitated by the IPR facilitation cell at Inter University Centre for IPR Studies (IUCIPRS), Cusat.

Related Stories

No stories found.

X
The New Indian Express
www.newindianexpress.com